Aptevo Therapeutics Stock (NASDAQ: APVO) stock price, news, charts, stock research, profile.
You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.
Other companies in Aptevo Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
Aptevo Therapeutics has a consensus price target of $14.00.
The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $0.1846 last updated September 25, 2024 at 12:36 PM EDT.
There are no upcoming dividends for Aptevo Therapeutics.
Aptevo Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Aptevo Therapeutics.
Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.